Vita Wharehouse Corp. – Trademark Portfolio

Entity Type: 03

Vita Wharehouse Corp. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include R V PHARMA and VITA GLOBE. The owner is based in Centereach, NY.

7 Rosa Ct.

Centereach, NY 11720

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Vita Wharehouse Corp.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Vita Wharehouse Corp. have?

Vita Wharehouse Corp. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Vita Wharehouse Corp. file in?

Vita Wharehouse Corp. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Vita Wharehouse Corp.'s most well-known trademarks?

Vita Wharehouse Corp.'s registered trademark portfolio includes well-known marks such as R V PHARMA and VITA GLOBE. These are among 2 currently registered trademarks in the portfolio.

What is Vita Wharehouse Corp.'s trademark registration success rate?

Vita Wharehouse Corp. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.